About 3 Trademarks found for “EX*YA”

Assessments and estimates conducted by engineers in the scientific and technical domains namely providing biostatistics in the fields of pharmaceutical, biotechnology and medical devices; Assessments and estimates conducted by engineers in the scientific and technical domains namely auditing the performance and quality of pharmacovigilance activities of others; Assessments and estimates conducted by engineers in the scientific and technical domains namely providing quality assurance services to companies in the fields of pharmaceuticals, biopharmaceuticals and medical devices; scientific and technical research namely, medical research, conducting clinical research and clinical trials in the fields of pharmaceuticals, biopharmaceuticals and medical devices, as well as the provision of scientific research information and consultation in the fields of clinical and medical research, pharmaceuticals, biopharmaceuticals, biotechnology, and medical devices; scientific and technical research consultation in the fields of pharmacovigilance, medical device vigilance, cosmetovigilance and conduct of the above vigilance activities for third parties; scientific and technical research by providing technical writing in the field of clinical research; research and development of new products for third parties in the field of medical research, pharmaceuticals, biopharmaceuticals, biotechnology, and medical devices.

Pharmaceutical preparations for the treatment of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders and spinal cord diseases; pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of metabolic disorders, namely metabolic myophathies, mucolipidoses, gangliosidoses, acidosis and alkadosis; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory pelvic diseases and inflammatory connective tissue diseases; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and sexually transmitted diseases; pharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the prevention of rejection in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of ocular disorders or diseases; antibiotics; pharmaceutical preparations for the treatment of diabetes; anti-infectives; antivirals; antifungal preparations.

Pharmaceutical preparations for the treatment of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders and spinal cord diseases; pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of metabolic disorders, namely metabolic myophathies, mucolipidoses, gangliosidoses, acidosis and alkadosis; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory pelvic diseases and inflammatory connective tissue diseases; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and sexually transmitted diseases; pharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the prevention of rejection in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of ocular disorders or diseases; antibiotics; pharmaceutical preparations for the treatment of diabetes; anti-infectives; antivirals; antifungal preparations.